Fit for life after cancer: Does exercise timing matter?
Files in This Item:
|17 DOConnor- Fit for life after cancer.pdf||167.66 kB||Adobe PDF||Download|
|Title:||Fit for life after cancer: Does exercise timing matter?||Authors:||O'Connor, Dominic; Daly, Ailish; Mulvin, Conor; Lennon, Olive||Permanent link:||http://hdl.handle.net/10197/11633||Date:||31-Aug-2018||Online since:||2020-10-20T11:11:51Z||Abstract:||Objectives: To assess the effects of a single exercise session per week for 6 weeks on quality of life (QoL), fatigue and exercise participation in male and female cancer survivors with follow-up at 6 months. A secondary aim was to identify if the timing of exercise delivery determined its effect. Methods: An exploratory prospective cohort study design was implemented. Twenty-five patients undergoing or who had completed cancer treatment (11 active treatment; 14 completed treatment) undertook exercise and educational sessions (Fit for Life) 1×/week. The Brief Fatigue Inventory (BFI), the European Organisation for Research and Treatment of Cancer QoL C-30 (EORTC QLQ C-30) and the Godin Leisure Time Exercise Questionnaire (GLTEQ) were used to assess fatigue, QoL and exercise levels, respectively. Participants were evaluated before and after the intervention, and after 6 months. Results: There was a significant group × time interaction for the GLTEQ at 6 months post in favour of exercising during active treatment (p=0.01). No other group × time interactions were observed across the EORTC QLQ C-30 or BFI. There was a significant main effect for time for EORTC QLQ C-30 Global with a significant increase observed between pre and 6 months post. Conclusions: Exercise 1×/week delivered during treatment may impact on long-term exercise participation in adult cancer survivors. This lower volume programme may improve QoL, but has minimal effect on fatigue suggesting an insufficient exercise dosage to impact this variable. This study generates interesting proof of concept results and may be helpful in the development of larger randomised controlled trials.||Funding Details:||European Commission Horizon 2020||Type of material:||Journal Article||Publisher:||BMJ||Journal:||BMJ Supportive and Palliative Care||Copyright (published version):||2018 the Authors or their Employers||Keywords:||Cancer; Exercise; Exercise timing; Follow-up; Rehabilitation interventions||DOI:||10.1136/bmjspcare-2018-001581||Language:||en||Status of Item:||Peer reviewed||ISSN:||2045-435X|
|Appears in Collections:||Public Health, Physiotherapy and Sports Science Research Collection|
Insight Research Collection
Show full item record
This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. For other possible restrictions on use please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.